Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Gerontology ; 69(10): 1167-1174, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37166337

RESUMEN

Measuring the abundance of biological molecules and their chemical modifications in blood and tissues has been the cornerstone of research and medical diagnoses for decades. Although the number and variety of molecules that can be measured have expanded exponentially, the blood biomarkers routinely assessed in medical practice remain limited to a few dozen, which have not substantially changed over the last 30-40 years. The discovery of novel biomarkers would allow, for example, risk stratification or monitoring of disease progression or the effectiveness of treatments and interventions, improving clinical practice in myriad ways. In this review, we combine the biomarker discovery concept with geroscience. Geroscience bridges aging research and translation to clinical applications by combining the framework of medical gerontology with high-technology medical research. With the development of geroscience and the rise of blood biomarkers, there has been a paradigm shift from disease prevention and cure to promoting health and healthy aging. New -omic technologies have played a role in the development of blood biomarkers, including epigenetic, proteomic, metabolomic, and lipidomic markers, which have emerged as correlates or predictors of health status, from disease to exceptional health.


Asunto(s)
Envejecimiento Saludable , Proteómica , Humanos , Biomarcadores , Envejecimiento , Metabolómica
2.
Methods Mol Biol ; 2399: 173-192, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35604557

RESUMEN

Human aging is a complex multifactorial process associated with a decline of physical and cognitive function and high susceptibility to chronic diseases, influenced by genetic, epigenetic, environmental, and demographic factors. This chapter will provide an overview on the use of epidemiological models with proteomics data as a method that can be used to identify factors that modulate the aging process in humans. This is demonstrated with proteomics data from human plasma and skeletal muscle, where the combination with epidemiological models identified a set of mitochondrial, spliceosome, and senescence proteins as well as the role of energetic pathways such as glycolysis, and electron transport pathways that regulate the aging process.


Asunto(s)
Modelos Epidemiológicos , Proteoma , Envejecimiento/genética , Envejecimiento/metabolismo , Humanos , Músculo Esquelético/metabolismo , Proteoma/metabolismo , Proteómica
3.
Aging Cell ; 19(2): e13080, 2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-31833194

RESUMEN

The global population of individuals over the age of 65 is growing at an unprecedented rate and is expected to reach 1.6 billion by 2050. Most older individuals are affected by multiple chronic diseases, leading to complex drug treatments and increased risk of physical and cognitive disability. Improving or preserving the health and quality of life of these individuals is challenging due to a lack of well-established clinical guidelines. Physicians are often forced to engage in cycles of "trial and error" that are centered on palliative treatment of symptoms rather than the root cause, often resulting in dubious outcomes. Recently, geroscience challenged this view, proposing that the underlying biological mechanisms of aging are central to the global increase in susceptibility to disease and disability that occurs with aging. In fact, strong correlations have recently been revealed between health dimensions and phenotypes that are typical of aging, especially with autophagy, mitochondrial function, cellular senescence, and DNA methylation. Current research focuses on measuring the pace of aging to identify individuals who are "aging faster" to test and develop interventions that could prevent or delay the progression of multimorbidity and disability with aging. Understanding how the underlying biological mechanisms of aging connect to and impact longitudinal changes in health trajectories offers a unique opportunity to identify resilience mechanisms, their dynamic changes, and their impact on stress responses. Harnessing how to evoke and control resilience mechanisms in individuals with successful aging could lead to writing a new chapter in human medicine.


Asunto(s)
Envejecimiento/fisiología , Inestabilidad Genómica/genética , Inflamación/metabolismo , Mitocondrias/metabolismo , Células Madre/metabolismo , Homeostasis del Telómero/genética , Envejecimiento/genética , Envejecimiento/metabolismo , Envejecimiento/efectos de la radiación , Animales , Senescencia Celular/genética , Senescencia Celular/fisiología , Epigénesis Genética/efectos de los fármacos , Epigénesis Genética/genética , Inestabilidad Genómica/efectos de los fármacos , Inestabilidad Genómica/efectos de la radiación , Geriatría/métodos , Humanos , Morbilidad , Proteostasis/genética , Proteostasis/fisiología , Especies Reactivas de Oxígeno/metabolismo , Células Madre/fisiología , Homeostasis del Telómero/fisiología
4.
Aging Cell ; 17(2)2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-29356348

RESUMEN

Mitochondrial function in human skeletal muscle declines with age. Most evidence for this decline comes from studies that assessed mitochondrial function indirectly, and the impact of such deterioration with respect to physical function has not been clearly delineated. We hypothesized that mitochondrial respiration in permeabilized human muscle fibers declines with age and correlates with phosphocreatine postexercise recovery rate (kPCr), muscle performance, and aerobic fitness. Mitochondrial respiration was assessed by high-resolution respirometry in saponin-permeabilized fibers from vastus lateralis muscle biopsies of 38 participants from the Baltimore Longitudinal Study of Aging (BLSA; 21 men, age 24-91 years) who also had available measures of peak oxygen consumption (VO2max ) from treadmill tests, gait speed in different tasks, 31 P magnetic resonance spectroscopy, isokinetic knee extension, and grip strength. Results indicated a significant reduction in mitochondrial respiration with age (p < .05) that was independent of other potential confounders. Mitochondrial respiratory capacity was also associated with VO2max , muscle strength, kPCr, and time to complete a 400-m walk (p < .05). A negative trend toward significance (p = .074) was observed between mitochondrial respiration and BMI. Finally, transcriptional profiling revealed a reduced mRNA expression of mitochondrial gene networks with aging (p < .05). Overall, our findings reinforce the notion that mitochondrial function declines with age and may contribute to age-associated loss of muscle performance and cardiorespiratory fitness.


Asunto(s)
Capacidad Cardiovascular/fisiología , Mitocondrias Musculares/metabolismo , Fuerza Muscular/fisiología , Músculo Esquelético/metabolismo , Consumo de Oxígeno/fisiología , Adulto , Anciano , Anciano de 80 o más Años , Envejecimiento , Femenino , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Oxidación-Reducción , Adulto Joven
5.
Diabetes ; 66(1): 170-176, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-27737951

RESUMEN

Whether individuals with insulin resistance (IR) but without criteria for diabetes exhibit reduced mitochondrial oxidative capacity is unclear; addressing this question could guide research for new therapeutics. We investigated 248 participants without diabetes from the Baltimore Longitudinal Study of Aging (BLSA) to determine whether impaired mitochondrial capacity is associated with prediabetes, IR, and duration and severity of hyperglycemia exposure. Mitochondrial capacity was assessed as the postexercise phosphocreatine recovery time constant (τPCr) by 31P-magnetic resonance spectroscopy, with higher τPCr values reflecting reduced capacity. Prediabetes was defined using the American Diabetes Association criteria from fasting and 2-h glucose measurements. IR and sensitivity were calculated using HOMA-IR and Matsuda indices. The duration and severity of hyperglycemia exposure were estimated as the number of years from prediabetes onset and the average oral glucose tolerance test (OGTT) 2-h glucose measurement over previous BLSA visits. Covariates included age, sex, body composition, physical activity, and other confounders. Higher likelihood of prediabetes, higher HOMA-IR, and lower Matsuda index were associated with longer τPCr. Among 205 participants with previous OGTT data, greater severity and longer duration of hyperglycemia were independently associated with longer τPC In conclusion, in individuals without diabetes a more impaired mitochondrial capacity is associated with greater IR and a higher likelihood of prediabetes.


Asunto(s)
Resistencia a la Insulina/fisiología , Imagen por Resonancia Magnética/métodos , Mitocondrias/metabolismo , Anciano , Anciano de 80 o más Años , Envejecimiento/fisiología , Diabetes Mellitus/patología , Diabetes Mellitus/fisiopatología , Femenino , Prueba de Tolerancia a la Glucosa , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Estado Prediabético/patología , Estado Prediabético/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA